logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Retrotope, Inc.


USPTO Granted Patents = 25



Forward Citations = 61

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Mikhail Sergeevich Shchepinov (25 out of 37 patents)

silverMedal Dragoslav Vidovic (4 out of 6 patents)

bronzeMedal Peter G Milner (3 out of 41 patents)

4.  Mikhail S Shchepinov (0 patent)


Core Competencies:
Oxidative Stress
Neurodegenerative Diseases
PUFA Derivatives
Isotopic Labeling
Amyotrophic Lateral Sclerosis
Retinal Diseases
Mitochondrial Deficiency
Genome Methylation
Therapeutic Uses
Food Supplements
Energy Processing Disorders
Cancer Therapies

25 patents:

1. 11510889 - Methods for inhibiting the progression of neurodegenerative diseases (2022-11-29),
2. 11510888 - Alleviating oxidative stress disorders with PUFA derivatives (2022-11-29),
3. 11491130 - Methods of treating amyotrophic lateral sclerosis (2022-11-08),
4. RE49238 - Alleviating oxidative stress disorders with PUFA derivatives (2022-10-10),
5. 11453637 - Site-specific isotopic labeling of 1,4-diene systems (2022-09-27),
6. 11447441 - Site-specific isotopic labeling of 1,4-diene systems (2022-09-20),
7. 11351143 - Methods of treating amyotrophic lateral sclerosis (2022-06-07),
8. 11285125 - Oxidative retinal diseases (2022-03-29),
9. 11241409 - Neurodegenerative disorders and muscle diseases implicating PUFAs (2022-02-08),
10. 11166930 - Isotopically modified components and therapeutic uses thereof (2021-11-09),
11. 10918126 - Isotopically modified compounds and their use as food supplements (2021-02-16),
12. 10730821 - Site-specific isotopic labeling of 1,4-diene systems (2020-08-04),
13. 10577304 - Site-specific isotopic labeling of 1,4-diene systems (2020-03-03),
14. 10154983 - Neurodegenerative disorders and muscle diseases implicating PUFAs (2018-12-18),
15. 10154978 - Disorders implicating PUFA oxidation (2018-12-18),
Retrotope, Inc. is a biotechnology company based in Los Altos, California, specializing in the development of innovative therapies that target age-related diseases and conditions. The company focuses on harnessing the potential of stable isotopes to create novel treatments aimed at improving healthspan and addressing the underlying mechanisms of aging. Retrotope's research encompasses a range of therapeutic areas, leveraging advanced scientific insights to enhance patient outcomes and promote longevity.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Retrotope, Inc.
25 Patents

#8 in Los Altos, CA

#3,154 in California

#13,350 in US

#25,681 in the World

Los Altos, CA (US)
Los Altos, CA, United States of America

Retrotope, Inc.

Forward Citations = 61

3 inventors:

goldMedal Mikhail Sergeevich Shchepinov (25 out of 37 patents)

silverMedal Dragoslav Vidovic (4 out of 6 patents)

bronzeMedal Peter G Milner (3 out of 41 patents)

4.  Mikhail S Shchepinov (0 patent)

Please report any incorrect information to [email protected]
Loading…